- Home
- ALM vs PHVS Comparison
ALM vs PHVS Comparison
Compare ALM & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALM | PHVS |
|---|---|---|
| Founded | N/A | 2015 |
| Country | Canada | Switzerland |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ALM | PHVS |
|---|---|---|
| Price | $8.77 | $26.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 9 |
| Target Price | $12.00 | ★ $39.44 |
| AVG Volume (30 Days) | ★ 3.0M | 469.3K |
| Earning Date | 02-20-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $21,591,798.00 | N/A |
| Revenue This Year | $78.23 | N/A |
| Revenue Next Year | $228.77 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 7.50 | N/A |
| 52 Week Low | $0.92 | $11.51 |
| 52 Week High | $10.68 | $29.80 |
Technical Indicators
Market Signals| Indicator | ALM | PHVS |
|---|---|---|
| Relative Strength Index (RSI) | 60.89 | 53.12 |
| Support Level | $8.57 | $25.27 |
| Resistance Level | $9.58 | $26.09 |
| Average True Range (ATR) | 0.51 | 1.35 |
| MACD | 0.06 | 0.12 |
| Stochastic Oscillator | 73.17 | 53.94 |
Price Performance
Historical ComparisonAbout ALM Almonty Industries Inc.
Almonty Industries Inc is engaged in the mining, processing, and shipping of tungsten concentrate from its Los Santos tungsten mine located near Salamanca, Spain - the Los Santos Mine, the processing and shipping of tungsten concentrate from its Panasqueira tin and tungsten mine in Covilha, Castelo Branco, Portugal - the Panasqueira Mine, the evaluation of its Valtreixal tin and tungsten mine project located in Western Spain in the province of Zamora - the Valtreixal Mine, as well as the exploration and evaluation of its Sangdong tungsten mine project located in Gangwon Province, Republic of Korea - the Sangdong Mine.
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.